Send us Feedback

Obagi Medical Products (OMPI)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

OMPI » Topics » SIGNATURES

This excerpt taken from the OMPI 8-K filed Jun 18, 2009.
SIGNATURES
 
 
   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
OBAGI MEDICAL PRODUCTS, INC.
  
       
Date: June 18, 2009
By:
/s/ PRESTON S. ROMM
  
   
Preston S. Romm
  
   
Chief Financial Officer
  
       
 

 
 
This excerpt taken from the OMPI 8-K filed Aug 11, 2008.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

Date: August 11, 2008

By:

/s/ Preston S. Romm

 

 

Preston S. Romm

 

 

Chief Financial Officer

 

3

This excerpt taken from the OMPI 8-K filed May 6, 2008.

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

Date:  May 6, 2008

By:

  /s/ Stephen A. Garcia

 

 

   Stephen A. Garcia

 

 

   Chief Financial Officer

 

3

This excerpt taken from the OMPI 8-K filed May 5, 2008.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

Date: May 5, 2008

By:

/s/ Stephen A. Garcia

 

 Stephen A. Garcia

 

 Chief Financial Officer

 

3

This excerpt taken from the OMPI 8-K filed Mar 27, 2008.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

Date:  March 27, 2008

By:

/s/ Steven R. Carlson

 

 

Name: Steven R. Carlson

 

 

Title: Chief Executive Officer

 

4

This excerpt taken from the OMPI 8-K filed Mar 3, 2008.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

Date: March 3, 2008

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

4

This excerpt taken from the OMPI 8-K filed Dec 14, 2007.

SIGNATURES

 

                Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date: December 14, 2007

 

 

 

 

 

By:

/s/ Stephen A. Garcia

 

 

 

 

 

 

 

Name: Stephen A. Garcia

 

 

 

 

 

 

 

Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

3

 

This excerpt taken from the OMPI 8-K filed Nov 13, 2007.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

Date: November 13, 2007

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

3

This excerpt taken from the OMPI 8-K filed Sep 11, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

Date: September 11, 2007

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

3


This excerpt taken from the OMPI 8-K filed Aug 9, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

 

 

Date: August 9, 2007

By:

/s/ Stephen A. Garcia

 

 

Name: Stephen A. Garcia

 

 

Title: Chief Financial Officer

 

 

 

3


This excerpt taken from the OMPI 10-Q filed Aug 7, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

Date: August 7, 2007

By:

/s/ STEVEN R. CARLSON

 

 

Steven R. Carlson

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

Date: August 7, 2007

By:

/s/ STEPHEN A. GARCIA

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

30


This excerpt taken from the OMPI 8-K filed Aug 6, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

Date: August 6, 2007

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

3


This excerpt taken from the OMPI 8-K filed Jun 4, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

Date: June 4, 2007

By:

/s/ Stephen A. Garcia

 

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

3


This excerpt taken from the OMPI 10-Q filed May 8, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

 

 

Date: May 8, 2007

By:

/s/ STEVEN R. CARLSON

 

 

 

Steven R. Carlson

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

Date: May 8, 2007

By:

/s/ STEPHEN A. GARCIA

 

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

28


This excerpt taken from the OMPI 8-K filed May 7, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

OBAGI MEDICAL PRODUCTS, INC.

 

 

Date: May 7, 2007

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

3


This excerpt taken from the OMPI 8-K filed Feb 26, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OBAGI MEDICAL PRODUCTS, INC.

 

 

Date: February 26, 2007

By:

/s/ Stephen A. Garcia

 

 

Stephen A. Garcia

 

 

Chief Financial Officer

 

4


EXCERPTS ON THIS PAGE:

8-K
Jun 18, 2009
8-K
Aug 11, 2008
8-K
May 6, 2008
8-K
May 5, 2008
8-K
Mar 27, 2008
8-K
Mar 3, 2008
8-K
Dec 14, 2007
8-K
Nov 13, 2007
8-K
Sep 11, 2007
8-K
Aug 9, 2007
10-Q
Aug 7, 2007
8-K
Aug 6, 2007
8-K
Jun 4, 2007
10-Q
May 8, 2007
8-K
May 7, 2007
8-K
Feb 26, 2007

RELATED TOPICS for OMPI:

"SIGNATURES" elsewhere:

Acorda Therapeutics (ACOR)
AEterna Zentaris (AEZS)
Affymetrix (AFFX)
Affymax (AFFY)
Alnylam Pharmaceuticals (ALNY)
Anika Therapeutics (ANIK)
American Oriental Bioengineering (AOB)
Cadence Pharmaceuticals (CADX)
Cambrex (CBM)
Cerus (CERS)
Crucell NV (CRXL)
Dendreon (DNDN)
Dyax (DYAX)
Emergent Biosolutions (EBS)
Enzon Pharmaceuticals (ENZN)
EPIX Pharmaceuticals (EPIX)
Exelixis (EXEL)
Halozyme Therapeutics (HALO)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Idenix Pharmaceuticals (IDIX)
ImmunoGen (IMGN)
Incyte (INCY)
InterMune (ITMN)
Martek Biosciences (MATK)
Medivation (MDVN)
Medarex (MEDX)
Neurocrine Biosciences (NBIX)
NGEN, INC. (NGEN)
Transcept Pharmaceuticals Inc (NOVC)
NPS Pharmaceuticals (NPSP)
ARCA biopharma, Inc. (NUVO)
Omrix Biopharmaceuticals (OMRI)
ONYX Pharmaceuticals (ONXX)
Optimer Pharmaceuticals (OPTR)
OSI Pharmaceuticals (OSIP)
Protalix BioTherapeutics (PLX)
Questcor Pharmaceuticals (QSC)
Repligen (RGEN)
Seattle Genetics (SGEN)
Sequenom (SQNM)
3SBio (SSRX)
Tongjitang Chinese Medicines Company (TCM)
Tercica (TRCA)
Targacept (TRGT)
Vanda Pharmaceuticals (VNDA)
ViroPharma (VPHM)
XOMA (XOMA)
ZymoGenetics (ZGEN)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki